Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +14.48% | +49.40% | 8.42 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.24% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.59% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +20.57% | +34.82% | 8.23 B USD | ||
| 1024 |  RGEN Repligen Corporation - Common Stock | 144.88 USD | +0.44% | +0.21% | +8.31% | -12.56% | 8.17 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +11.36% | +292.01% | 8.14 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +6.47% | -1.00% | 8.00 B USD | ||
| 1035 |  ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1036 |  BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 297.56 USD | +0.48% | -0.36% | +1.29% | -11.62% | 7.96 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +17.59% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.99% | +53.69% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +22.64% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.21% | +69.74% | 7.26 B USD | ||
| 1120 |  LNTH Lantheus Holdings, Inc. - Common Stock | 105.39 USD | -0.24% | +3.83% | +0.91% | +88.00% | 6.86 B USD | ||
| 1122 |  PACS PACS Group, Inc. Common Stock | 43.29 USD | +0.12% | -4.12% | +23.69% | +236.89% | 6.85 B USD | ||
| 1156 |  SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.34% | +82.21% | 6.55 B USD | ||
| 1159 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +30.18% | +66.02% | 6.55 B USD | ||
| 1161 |  CHE Chemed Corp | 492.28 USD | +0.80% | +1.43% | +17.61% | +6.45% | 6.53 B USD | ||
| 1176 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.46 USD | -3.63% | -6.12% | +15.05% | +139.06% | 6.40 B USD |
Notizie Titoli del Settore Sanitario
Glencore converte un’obbligazione da 25 milioni di dollari in Osisko Metals
Stifel avvia copertura di Arrowhead Pharma con rating buy
Dexcom ottiene l’autorizzazione di Health Canada per il G7 15 Day CGM
Perché il titolo Erasca sta scendendo oggi?
Astrana Health nomina nuovi dirigenti per l’area medica e la trasformazione aziendale
Erasca pianifica un’offerta azionaria da 500 milioni per finanziare la ricerca
Il titolo Erasca crolla dopo l’annuncio di un’offerta azionaria da 500 milioni
Gainers Titoli del Settore Sanitario
 XAIR Beyond Air, Inc. - Common Stock | 7.49 | +1683.33% |
 QTTB Q32 Bio Inc. - Common Stock | 21.38 | +90.72% |
 AGEN Agenus Inc. - Common Stock | 6.12 | +82.69% |
 SRXH SRX Health Solutions, Inc. Common Stock | 2.78 | +31.13% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 | +23.97% |
 TOIIW The Oncology Institute, Inc. - Warrant | 0.0597 | +19.64% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 | +19.50% |
 GALT Galectin Therapeutics Inc. - Common Stock | 4.60 | +13.30% |
Losers Titoli del Settore Sanitario
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.49 | -33.78% |
 AEON AEON Biopharma, Inc. Class A Common Stock | 0.32 | -33.33% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0537 | -29.34% |
 BIVI BioVie Inc. - Common stock | 1.64 | -27.75% |
 ZCMD Zhongchao Inc. - Class A Ordinary Shares | 1.51 | -25.62% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 14.21 | -25.01% |
 HUMAW Humacyte, Inc. - Warrant | 0.0076 | -24.00% |
 AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 | -21.58% |